{"product_id":"reactifargan-2-crema-20g","title":"Reactifargan 2% cream 20g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal symptomatic treatment for insect bites and other localized skin irritation phenomena such as redness, burning, itching and sunburn.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Eczema Secreting lesions. Children under 2 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProlonged and inappropriate use of the product can give rise to allergic sensitization phenomena with consequent worsening of symptoms. If this occurs, treatment should be suspended and the situation reassessed. If applied to very large areas of the skin REACTIFARGAN may cause drowsiness (see section 4.7). Given that the application of REACTIFARGAN can delay the healing process, it must not be used more than 3-4 consecutive days on lesions in which this phenomenon is taking place. In the case of sunburn, apply the product and avoid further exposure of the irritated skin to the sun. If skin rashes, irritation and burning phenomena occur, treatment should be suspended. \u003cb\u003eImportant information about some excipients\u003c\/b\u003e REACTIFARGAN contains \u003cb\u003emethyl p-hydroxybenzoate\u003c\/b\u003e e \u003cb\u003epropyl p-hydroxybenzoate\u003c\/b\u003e which can cause allergic reactions (even delayed). REACTIFARGAN contains lavender oil, a fragrance which in turn contains D-Limonene, geraniol and linalool which can cause allergic reactions; REACTIFARGAN contains octyl methoxycinnamate which in turn contains butylated hydroxytoluene which may cause localized skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe side effects reported below arise from post-marketing and have an unknown frequency (the frequency cannot be established from the available data).\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eClassification by organs and systems\u003c\/b\u003e | \u003cb\u003eFrequency not known\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders | Dermatitis edema erythema bullous lesions photosensitivity\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51131364933959,"sku":"002516060","price":13.45,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-reactifargan-2-crema-20g-farmacia-dottor-tili-1213791913.jpg?v=1767115768","url":"https:\/\/www.dottortili.com\/en-eu\/products\/reactifargan-2-cream-20g","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}